Eszopiclone and Vyvanse drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Eszopiclone (eszopiclone) and Vyvanse (lisdexamfetamine dimesylate). Common drug interactions include respiratory tract infection among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Eszopiclone and Vyvanse. It is created by eHealthMe based on reports of 41 people who take the same drugs from the FDA, and is updated regularly.

What is Eszopiclone?

Eszopiclone has active ingredients of eszopiclone. It is often used in insomnia. eHealthMe is studying from 4,258 Eszopiclone users. Check the latest studies of Eszopiclone.

What is Vyvanse?

Vyvanse has active ingredients of lisdexamfetamine dimesylate. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 35,868 Vyvanse users. Check the latest studies of Vyvanse.

On Jul, 11, 2026

41 people who take Eszopiclone and Vyvanse together, and have interactions are studied.

Eszopiclone and Vyvanse drug interactions.

What are the common drug interactions of Eszopiclone and Vyvanse, by gender? *:

female:

Respiratory tract infection
Sinusitis (inflammation of sinus)
Productive cough
Anxiety
Dyspnoea (difficult or laboured respiration)
Nasopharyngitis (inflammation of the nasopharynx)
Weight increased
Angioplasty
Fatigue (feeling of tiredness)
Suicidal ideation

male:

Drug ineffective
Anxiety
Balance disorder
Blood urine present
Bone density decreased
Chronic sinusitis (long lasting inflammation of the paranasal sinuses)
Dysstasia (difficulty in standing)
Emotional distress
Gait disturbance
General physical health deterioration (weak health status)

What are the common drug interactions of Eszopiclone and Vyvanse, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Acute psychosis (period of mentally unstable behaviour)
Anxiety
Hypertension (high blood pressure)
Nasopharyngitis (inflammation of the nasopharynx)
Respiratory syncytial virus infection (viral disease of respiratory system)
Somnambulism (sleep walking)
Weight increased

30-39:

Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
Discomfort
Pancreatitis relapsing
Rash
Antinuclear antibody positive
Arthralgia (joint pain)
Asthma
Blepharospasm (any abnormal contraction or twitch of the eyelid)
Blood pressure increased
Chest pain

40-49:

Peripheral swelling
Abdominal pain
Blood pressure increased
Heart rate increased
Hepatic failure (liver failure)
Loss of consciousness
Oral candidiasis (fungal infection of mouth)
Pain
Pyrexia (fever)
Rash

50-59:

Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Dry mouth
Dysgeusia (disorder of the sense of taste)
Oral mucosal blistering (mouth ulcer)
Anaemia (lack of blood)

60+:

Productive cough
Respiratory tract infection
Sinusitis (inflammation of sinus)
Dyspnoea (difficult or laboured respiration)
Pneumonia
Anger
Anxiety
Nasopharyngitis (inflammation of the nasopharynx)
Obstruction

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 19 people, 46.34%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 14 people, 34.15%
Drowsiness: 6 people, 14.63%
Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 3 people, 7.32%

* Approximation only. Some reports may have incomplete information.

Do you take Eszopiclone and Vyvanse?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously